NinePointTwo Capital’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	$329K	Buy	+37,496	New	+$329K	0.13%	98
2023 Q3	–	Sell	-8,444	Closed	-$213K	–	335
2023 Q2	$213K	Buy	+8,444	New	+$213K	0.08%	196
2023 Q1	–	Sell	-11,774	Closed	-$217K	–	314
2022 Q4	$217K	Buy	+11,774	New	+$217K	0.09%	95